Comparison of Amitriptyline, Cyclobenzaprine, and Placebo in the Treatment of Fibromyalgia

Arthritis & Rheumatism

Volumn 37, Issue 1, 1994, Pages 32-40

  Carette, Simon ^a,b,c,d,g,h   Bell, Mary J ^a,b,c,d,g,h   Reynolds, W John ^a,b,c,d,g,h   Haraoui, Boulos ^a,b,c,d,g,h   Mccain, Glenn A ^a,b,c,d,g,h   Bykerk, Vivian P ^{a,b,c,d,e,g,h}   Edworthy, Steven M ^{a,b,c,d,f,g,h}   Baron, Murray ^a,b,c,d,g,h   Koehler, Barry E ^{a,b,c,d,e,g,h}   Fam, Adel G ^a,b,c,d,g,h   Bellamy, Nicholas ^a,b,c,d,g,h   Guimont, Chantal ^a,b,c,d,g,h  

^a UNIVERSITÉ LAVAL   (Canada)

^b UNIVERSITY OF TORONTO   (Canada)

^c UNIVERSITÉ DE MONTRÉAL   (Canada)

^d UNIVERSITY OF WESTERN ONTARIO   (Canada)

^e University of Calgary ^*  (Canada)

^f UNIVERSITY OF CALGARY   (Canada)

^g MCGILL UNIVERSITY   (Canada)

^h UNIVERSITY OF CALGARY   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

AMITRIPTYLINE; CYCLOBENZAPRINE; NAPROXEN; PLACEBO; TRIAZOLAM;

ABDOMINAL PAIN; ADULT; ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOSE RESPONSE; DOUBLE BLIND PROCEDURE; DRUG EFFICACY; DRUG TOLERANCE; FEMALE; FIBROMYALGIA; HEADACHE; HUMAN; LONG TERM CARE; MAJOR CLINICAL STUDY; MALE; MINNESOTA MULTIPHASIC PERSONALITY INVENTORY; MULTICENTER STUDY; ORAL DRUG ADMINISTRATION; PATIENT COMPLIANCE; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; RASH; SOMNOLENCE; VERTIGO; WEIGHT GAIN;

AMITRIPTYLINE; ANTIDEPRESSIVE AGENTS, TRICYCLIC; DOUBLE-BLIND METHOD; FIBROMYALGIA; PAIN MEASUREMENT; PATIENT COMPLIANCE; PLACEBOS;

EID: 0028085188     PISSN: 00043591     EISSN: 15290131     Source Type: Journal    
DOI: 10.1002/art.1780370106     Document Type: Article

References (34)

1. Primary fibromyalgia (fibrositis): clinical study of 50 patients with matched controls
2. Observations relating to referred pain, visceromotor reflexes and other associated phenomena
3. Musculoskeletal symptoms and Non‐REM sleep disturbance in patients with “fibrositis syndrome” and healthy subjects
4. Induction of neurasthenic musculoskeletal pain syndrome by selective sleep stage deprivation
5. Fibrositis and psychologic disturbance
6. Psychological factors associated with primary fibromyalgia syndrome
7. Psychological status in primary fibrositis and fibrositis associated with rheumatoid arthritis
8. 133xenon clearance from exercising muscle
9. Neurohormonal aspects of fibromyalgia syndrome
10. The natural history of fibromyalgia
11. Pain, functional disability and psychological status: a 12 month study of severity in fibromyalgia
12. Evaluation of amitriptyline in primary fibrositis: a double‐blind, placebo‐controlled study
13. A randomized, controlled trial of amitriptyline and naproxen in the treatment of patients with fibromyalgia
14. Improvements in pain responsiveness in patients with fibrositis after successful treatment with amitriptyline
15. Clinical usefulness of amitriptyline in fibromyalgia: the results of 23 N‐of‐1 randomized controlled trials
16. A comparison of cyclobenzaprine and placebo in the management of fibrositis: a double‐blind controlled study
17. A randomized trial of cyclobenzaprine for the treatment of fibromyalgia
18. The American College of Rheumatology 1990 criteria for the classification of fibromyalgia: report of the multicenter criteria committee
19. The McGill Pain Questionnaire: major properties and scoring methods
20. The Sickness Impact Profile: development and final revision of a health status measure
21. Measurement of patient outcome in arthritis
22. Measuring physical discal and psychosocial function in patients with low back pain
23. Functional ability and work status in patients with fibromyalgia
24. Measuring health status in arthritis: the Arthritis Impact Measurement Scales
25. Treatment of fibromyalgia syndrome
26. Criteria for response to treatment in fibromyalgia (abstract)
27. Treatment of primary fibrositis/fibromyalgia syndrome with ibuprofen and alprazolam: a double‐blind, placebo‐controlled study
28. Clinical trials in fibrositis: a critical review and future directions
29. A controlled trial of corticosteroid injections into facet joints for chronic low back pain
30. Problems with the MMPI
31. Is the MMPI invalid for assessing psychological disturbance in pain related organic conditions
32. Relationship of clinical features with psychological status in primary fibromyalgia